Alliancebernstein L.P. Has $416.44 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Alliancebernstein L.P. decreased its position in The Cooper Companies, Inc. (NASDAQ:COO) by 10.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,529,990 shares of the medical device company’s stock after selling 521,421 shares during the period. Alliancebernstein L.P. owned about 2.27% of Cooper Companies worth $416,442,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Byrne Asset Management LLC acquired a new stake in shares of Cooper Companies during the 4th quarter valued at about $33,000. OFI Invest Asset Management acquired a new stake in Cooper Companies during the fourth quarter valued at approximately $34,000. New Age Alpha Advisors LLC bought a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $38,000. West Financial Advisors LLC acquired a new position in shares of Cooper Companies in the 4th quarter worth approximately $49,000. Finally, Atala Financial Inc bought a new position in shares of Cooper Companies during the 4th quarter worth approximately $51,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.7 %

COO stock opened at $84.35 on Tuesday. The business has a fifty day moving average of $89.15 and a 200-day moving average of $97.03. The company has a market cap of $16.87 billion, a P/E ratio of 43.26, a PEG ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a twelve month low of $77.05 and a twelve month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Piper Sandler restated an “overweight” rating and issued a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. JPMorgan Chase & Co. reduced their target price on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Friday, March 7th. Morgan Stanley dropped their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Wells Fargo & Company raised their target price on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Cooper Companies currently has an average rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.